Guardant Health, Inc. (GH): Price and Financial Metrics

Guardant Health, Inc. (GH)

Today's Latest Price: $157.30 USD

2.62 (-1.64%)

Updated Jan 25 6:55pm

Add GH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 188 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

GH Stock Summary

  • Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than just 5.26% of US equities in our set.
  • With a price/sales ratio of 58.93, Guardant Health Inc has a higher such ratio than 94.9% of stocks in our set.
  • With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.79% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Guardant Health Inc, a group of peers worth examining would be LASR, MDLA, WORK, TNDM, and PFPT.
  • GH's SEC filings can be seen here. And to visit Guardant Health Inc's official web site, go to

GH Stock Price Chart Interactive Chart >

Price chart for GH

GH Price/Volume Stats

Current price $157.30 52-week high $168.52
Prev. close $159.92 52-week low $55.90
Day low $152.06 Volume 877,500
Day high $163.21 Avg. volume 1,229,487
50-day MA $130.02 Dividend yield N/A
200-day MA $100.83 Market Cap 15.73B

Guardant Health, Inc. (GH) Company Bio

Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.

GH Latest News Stream

Event/Time News Detail
Loading, please wait...

GH Latest Social Stream

Loading social stream, please wait...

View Full GH Social Stream

Latest GH News From Around the Web

Below are the latest news stories about Guardant Health Inc that investors may wish to consider to help them evaluate GH as an investment opportunity.

Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe

BARCELONA, Spain & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, have agreed to enter into a partnership to establish in-house liquid biopsy testing services, using Guardant Health’s industry-leading proprietary digital sequencing platform, at VHIO’s facility in Barcelona, Spain. The service is expected to become operational in

Business Wire | January 18, 2021

Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid Biopsy to Advance Precision Oncology in Early to Late-Stage Colorectal Cancer

Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will present data highlighting the clinical utility of Guardant Health’s proprietary blood tests to make a meaningful impact on patient care at the upcoming virtual 2021 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium being held January 15-17, 2021.

Yahoo | January 14, 2021

The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ...

Benzinga | January 13, 2021

Guardant Health to launch blood test for colon cancer recurrence this year

Guardant Health ([[GH]] +1.1%) will launch the first liquid biopsy test for detection of early-stage colon cancer recurrence in February, CEO Helmy Eltoukhy said. The test will be called Guardant Reveal.Reveal will have a seven-day turnaround time, Eltoukhy said in an interview. Additional cancer types to follow.The company also expects to...

Seeking Alpha | January 12, 2021

Guardant Health (GH) Presents At J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by Guardant Health, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 12, 2021

Read More 'GH' Stories Here

GH Price Returns

1-mo N/A
3-mo 42.35%
6-mo 82.84%
1-year 102.03%
3-year N/A
5-year N/A
YTD 22.05%
2020 64.93%
2019 107.87%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8388 seconds.